Magnesiumaspartaat
Generic name
Magnesiumaspartaat
Brand name
ATC Code
A12CC05
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No pharmacokinetic data available [SmPC]
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Treatment and prophylaxis of magnesium deficiency |
|---|
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
OTHER MINERAL SUPPLEMENTS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Sodium | ||
|---|---|---|
| A12CA01 | ||
| Zinc | ||
|---|---|---|
| A12CB01 | ||
| Magnesium | ||
|---|---|---|
| A12CC01 | ||
| A12CC04 | ||
| A12CC03 | ||
| A12CC02 | ||
| Selenium | ||
|---|---|---|
| A12CE02 | ||
| Other mineral products | ||
|---|---|---|
| A12CX | ||
| MAGNESIUM | ||
|---|---|---|
| A12CC01 | ||
| A12CC04 | ||
| A12CC03 | ||
| A12CC02 | ||
| OTHER MINERAL PRODUCTS | ||
|---|---|---|
| A12CX | ||
Reference
- Kora Corporation Ltd t/a Kora Healthcare, SmPC Magnence (RVG 127731) 2-11-2022, Geneesmiddeleninformatiebank.nl
Changes
Therapeutic Drug Monitoring
Overdose
